Back to Authors

Yin, Junxiang

https://orcid.org/0000-0002-9675-3802

A5101473203 | I1324766304

Mayo Clinic

Barrow Neurological Institute

Citations 6

The Pituitary Adenylate Cyclase Activating Polypeptide Levels are Associated with Pathological Features of Alzheimer’s Disease (P4.201)

Neurology | December 7, 2023 | Volume: 82 | Issue: 10_supplement | Pages: No page available

10.1212/wnl.82.10_supplement.p4.201

Sirtuin 3 is down-regulated in Apolipoprotein E4 carriers with Alzheimer’s disease (P5.011)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p5.011

Effect of ApoE isoforms on mitochondria in Alzheimer disease

Neurology | May 27, 2020 | Volume: 94 | Issue: 23 | Pages: No page available

10.1212/wnl.0000000000009582 | PMID 32457210

P1‐244: THE EFFECT OF SIRTUIN 3 ON TAU ACETYLATION IN ALZHEIMER'S DISEASE

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2018.06.249

Association of Pituitary Adenylate Cyclase–Activating Polypeptide With Cognitive Decline in Mild Cognitive Impairment Due to Alzheimer Disease

JAMA Neurology | January 19, 2015 | Volume: 72 | Issue: 3 | Pages: 333

10.1001/jamaneurol.2014.3625 | PMID 25599520

Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease

Neurology | April 10, 2014 | Volume: 82 | Issue: 19 | Pages: 1724-1728

10.1212/wnl.0000000000000417 | PMID 24719484